Clinical trial portfolio review showing a team member pointing to performance metrics on a large screen

When Portfolio Reviews Become Reconciliation Exercises

Portfolio reviews are meant to provide clarity. They are designed to give sponsors a clear, shared understanding of how their clinical trials are progressing, where risks are emerging, and what decisions need to be made next. At their best, portfolio reviews align leadership, clinical operations, and data teams around a common picture of reality. But for many sponsors, portfolio reviews

Read More »
hidden cost of running edc etmf and ctms as separate systems

The Hidden Cost of Running EDC, eTMF, and CTMS as Separate Systems

In many sponsor organizations, Electronic Data Capture (EDC), electronic Trial Master File (eTMF), and Clinical Trial Management Systems (CTMS) are treated as distinct operational domains. Each system has its own purpose, its own workflows, and its own users. On paper, this separation can appear logical—even reassuring. Best‑in‑class tools are selected for each function, teams are trained accordingly, and responsibilities are

Read More »
Sponsors lose trust in trial data due to fragmented systems and limited visibility

Why Sponsors Lose Trust in Their Trial Data (and How It Happens Gradually)

Sponsors lose trust in their trial data gradually, not all at once. Trust erodes slowly, often quietly, as small mismatches, delays, and workarounds accumulate across the life of a study. By the time trust is openly questioned, the underlying causes have usually been in place for months—or even years. Why Do Sponsors Lose Trust? This loss of confidence is rarely

Read More »
Shopping Basket